These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31450557)

  • 1. The Spirocyclic Imine from a Marine Benthic Dinoflagellate, Portimine, Is a Potent Anti-Human Immunodeficiency Virus Type 1 Therapeutic Lead Compound.
    Izumida M; Suga K; Ishibashi F; Kubo Y
    Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31450557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifouling activity of portimine, select semisynthetic analogues, and other microalga-derived spirocyclic imines.
    Brooke DG; Cervin G; Champeau O; Harwood DT; Pavia H; Selwood AI; Svenson J; Tremblay LA; Cahill PL
    Biofouling; 2018 Sep; 34(8):950-961. PubMed ID: 30539667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro investigation of the genotoxicity of portimine, a cyclic imine toxin produced by the dinoflagellate Vulcanodinium rugosum, on human hepatic HepaRG cells.
    Hogeveen K; Huet S; Besnard C; Murray JS; Harwood DT; Selwood AI; Fessard V
    Toxicol In Vitro; 2021 Jun; 73():105125. PubMed ID: 33631200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kabirimine, a New Cyclic Imine from an Okinawan Dinoflagellate.
    Hermawan I; Higa M; Hutabarat PUB; Fujiwara T; Akiyama K; Kanamoto A; Haruyama T; Kobayashi N; Higashi M; Suda S; Tanaka J
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31200525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
    Martinez ZS; Castro E; Seong CS; Cerón MR; Echegoyen L; Llano M
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5731-41. PubMed ID: 27431232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus type (HIV-1) replication by some diversely functionalized spirocyclopropyl derivatives.
    Witvrouw M; Pannecouque C; De Clercq E; Fernández-Alvarez E; Marco JL
    Arch Pharm (Weinheim); 1999 May; 332(5):163-6. PubMed ID: 10366901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening of HIV-1 replication inhibitors by using pseudotyped virus system].
    Cao YL; Guo Y
    Yao Xue Xue Bao; 2008 Mar; 43(3):253-8. PubMed ID: 18630260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A.
    Tietjen I; Williams DE; Read S; Kuang XT; Mwimanzi P; Wilhelm E; Markle T; Kinloch NN; Naphen CN; Tenney K; Mesplède T; Wainberg MA; Crews P; Bell B; Andersen RJ; Brumme ZL; Brockman MA
    Antiviral Res; 2018 Apr; 152():94-103. PubMed ID: 29476895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summer bloom of Vulcanodinium rugosum in Cienfuegos Bay (Cuba) associated to dermatitis in swimmers.
    Moreira-González AR; Comas-González A; Valle-Pombrol A; Seisdedo-Losa M; Hernández-Leyva O; Fernandes LF; Chomérat N; Bilien G; Hervé F; Rovillon GA; Hess P; Alonso-Hernández CM; Mafra LL
    Sci Total Environ; 2021 Feb; 757():143782. PubMed ID: 33229082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidic polysaccharides isolated from marine algae inhibit the early step of viral infection.
    Ueno M; Nogawa M; Siddiqui R; Watashi K; Wakita T; Kato N; Ikeda M; Okimura T; Isaka S; Oda T; Ariumi Y
    Int J Biol Macromol; 2019 Mar; 124():282-290. PubMed ID: 30452989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity, fractionation and dereplication of extracts of the dinoflagellate Vulcanodinium rugosum, a producer of pinnatoxin G.
    Geiger M; Desanglois G; Hogeveen K; Fessard V; Leprêtre T; Mondeguer F; Guitton Y; Hervé F; Séchet V; Grovel O; Pouchus YF; Hess P
    Mar Drugs; 2013 Sep; 11(9):3350-71. PubMed ID: 24002102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.
    Hartman TL; Yang L; Helfrick AN; Hassink M; Shank NI; George Rosenker K; Scerba MT; Saha M; Hughes E; Wang AQ; Xu X; Gupta P; Buckheit RW; Appella DH
    Antiviral Res; 2016 Oct; 134():216-225. PubMed ID: 27568924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor.
    Ferris RG; Hazen RJ; Roberts GB; St Clair MH; Chan JH; Romines KR; Freeman GA; Tidwell JH; Schaller LT; Cowan JR; Short SA; Weaver KL; Selleseth DW; Moniri KR; Boone LR
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4046-51. PubMed ID: 16189079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkaloids from the Sponge Stylissa carteri Present Prospective Scaffolds for the Inhibition of Human Immunodeficiency Virus 1 (HIV-1).
    O'Rourke A; Kremb S; Bader TM; Helfer M; Schmitt-Kopplin P; Gerwick WH; Brack-Werner R; Voolstra CR
    Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26861355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillixanthone A, a marine-derived dual-coreceptor antagonist as anti-HIV-1 agent.
    Tan S; Yang B; Liu J; Xun T; Liu Y; Zhou X
    Nat Prod Res; 2019 May; 33(10):1467-1471. PubMed ID: 29258357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regiospecific synthesis and anti-human immunodeficiency virus activity of novel 5-substituted N-alkylcarbamoyl and N,N-dialkylcarbamoyl 1,2,3-triazole-TSAO analogues.
    Velázquez S; Alvarez R; Pérez C; Gago F; De Clercq E; Balzarini J; Camarasa MJ
    Antivir Chem Chemother; 1998 Nov; 9(6):481-9. PubMed ID: 9865386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Structure Analysis Reveals a Transient Portimine B Hydrate.
    Wood JS; Tang J; Strangman WK; Williamson RT
    J Nat Prod; 2024 Aug; 87(8):2120-2125. PubMed ID: 39054259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
    Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the effect of temporary removal of HIV drug pressure.
    Witvrouw M; Pannecouque C; Desmyter J; De Clercq E; Andries K
    Antiviral Res; 2000 Jun; 46(3):215-21. PubMed ID: 10867159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.